drugset / Trial / NCT02416271
The Forteo Alendronate Comparator Trial
RandomizedParallel-groupDouble-blindTreatment
Summary
The main purpose of this study is to evaluate the effects of teriparatide with those of alendronate on spine bone mineral density (BMD) and other osteoporosis factors in postmenopausal women with osteoporosis.
Timeline
- Start
- 2001-04
- Primary completion
- 2003-05
- Completion
- 2003-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Alendronic Acid | Small molecule | 10 mg | Oral |
| Subject | Teriparatide | Protein / enzyme biologic | 20 ug | Subcutaneous |